News

In clinical trials, the drug demonstrated clinically significant blood pressure reductions. The US filing was based on a robust clinical trial program involving more than 5,000 hypertensive patients.

The phase III trial, named Study 112E, was a long-term multi-center, single-arm safety study of Pennsaid applied by patients with symptoms of osteoarthritis (OA) of the knee. In

Results of the clinical trial, which investigated the safety, tolerability and anti-viral activity of ANA380, an oral prodrug of ANA317 (LB80317), in patients with lamivudine-resistant hepatitis B virus

Preliminary data from the phase I/II single escalating dose clinical study demonstrated an excellent tolerability profile and positive efficacy on glucose reduction supporting once-a-week dosing. Furthermore, the longer

Talabostat inhibits dipeptidyl peptidases (DPPs), which are enzymes that regulate biological processes, including tumor growth and immune responses. As a stromal targeted agent, talabostat inhibits fibroblast activation protein

The court re-affirmed its January 2006 ruling, stating that the patent related to the use of Emisphere's proprietary technology with GLP molecules belonged to Emisphere under the terms

The study was conducted by Erica Dawson of the Yale School of Management, Kenneth Savitsky of Williams College, and David Dunning of Cornell University. According to the research,

Chronic back pain, estimated to affect 26 million Americans, has recently been linked to blockage of blood vessels supplying the lower back, leading to a condition referred to

The AIR system delivers insulin via inhalation based on Alkermes’ AIR pulmonary drug delivery technology. The system uses a small, simple inhaler that fits in the palm of